OBJECTIVES: To compare the effect of prefracture depressive illness and postfracture depressive symptoms on changes in physical performance after hip fracture. DESIGN: Longitudinal observational cohort. SETTING: Baltimore metropolitan area. PARTICIPANTS: Older adults with hip fracture (N = 255). MEASUREMENTS: Prefracture depressive illness (from medical records) at baseline and postfracture depressive symptoms at 2 months (using the Center for Epidemiologic Studies Depression Scale) were measured. Physical performance was measured 2, 6, and 12 months after fracture using the Short Physical Performance Battery (SPPB), a composite metric of functional status with a score ranging from 0 to 12. Weighted estimating equations were used to assess mean SPPB over time, comparing participants with and without prefracture depressive illness and subjects with and without postfracture depressive symptoms. RESULTS: Participants with prefracture depressive illness had an SPPB increase of 0.4 units (95% confidence interval (CI) = -0.5-1.3) from 2 to 6 months, smaller than the increase of 1.0 SPPB unit (95% CI = 0.4-1.6) in those without prefracture depressive illness. Participants with postfracture depressive symptoms had an SPPB increase of 0.2 units (95% CI = -1.0-1.5) from 2 to 12 months, and those without postfracture depressive symptoms had a larger increase of 1.2 units (95% CI = 0.6-1.8) over the same period. Nevertheless, prefracture depressive illness and postfracture depressive symptoms were not significantly associated with SPPB. CONCLUSIONS: Neither prefracture depressive illness nor postfracture depressive symptoms were significantly associated with changes in physical performance after hip fracture, but the magnitude of estimates suggested possible clinically meaningful effects on functional recovery.
OBJECTIVES: To compare the effect of prefracture depressive illness and postfracture depressive symptoms on changes in physical performance after hip fracture. DESIGN: Longitudinal observational cohort. SETTING: Baltimore metropolitan area. PARTICIPANTS: Older adults with hip fracture (N = 255). MEASUREMENTS: Prefracture depressive illness (from medical records) at baseline and postfracture depressive symptoms at 2 months (using the Center for Epidemiologic Studies Depression Scale) were measured. Physical performance was measured 2, 6, and 12 months after fracture using the Short Physical Performance Battery (SPPB), a composite metric of functional status with a score ranging from 0 to 12. Weighted estimating equations were used to assess mean SPPB over time, comparing participants with and without prefracture depressive illness and subjects with and without postfracture depressive symptoms. RESULTS:Participants with prefracture depressive illness had an SPPB increase of 0.4 units (95% confidence interval (CI) = -0.5-1.3) from 2 to 6 months, smaller than the increase of 1.0 SPPB unit (95% CI = 0.4-1.6) in those without prefracture depressive illness. Participants with postfracture depressive symptoms had an SPPB increase of 0.2 units (95% CI = -1.0-1.5) from 2 to 12 months, and those without postfracture depressive symptoms had a larger increase of 1.2 units (95% CI = 0.6-1.8) over the same period. Nevertheless, prefracture depressive illness and postfracture depressive symptoms were not significantly associated with SPPB. CONCLUSIONS: Neither prefracture depressive illness nor postfracture depressive symptoms were significantly associated with changes in physical performance after hip fracture, but the magnitude of estimates suggested possible clinically meaningful effects on functional recovery.
Authors: J Magaziner; W Hawkes; J R Hebel; S I Zimmerman; K M Fox; M Dolan; G Felsenthal; J Kenzora Journal: J Gerontol A Biol Sci Med Sci Date: 2000-09 Impact factor: 6.053
Authors: Panayotes Demakakos; Rachel Cooper; Mark Hamer; Cesar de Oliveira; Rebecca Hardy; Elizabeth Breeze Journal: PLoS One Date: 2013-07-09 Impact factor: 3.240
Authors: Wei Duan-Porter; Tien N Vo; Kristen Ullman; Lisa Langsetmo; Elsa S Strotmeyer; Brent C Taylor; Adam J Santanasto; Peggy M Cawthon; Anne B Newman; Eleanor M Simonsick; Teresa M Waters; Kristine E Ensrud Journal: J Gerontol A Biol Sci Med Sci Date: 2019-09-15 Impact factor: 6.053
Authors: Mohammad Auais; Fadi Al-Zoubi; Alyssa Matheson; Kelcie Brown; Jay Magaziner; Simon D French Journal: Health Soc Care Community Date: 2019-08-25
Authors: Alan M Rathbun; Jay Magaziner; Michelle D Shardell; Thomas J Beck; Laura M Yerges-Armstrong; Denise Orwig; Gregory E Hicks; Alice S Ryan; Marc C Hochberg Journal: Bone Date: 2019-12-05 Impact factor: 4.398
Authors: Jennifer M Kirk; Jay Magaziner; Michelle D Shardell; Alice S Ryan; Ann L Gruber-Baldini; Denise Orwig; Marc C Hochberg; Alan M Rathbun Journal: Age Ageing Date: 2021-11-10 Impact factor: 12.782
Authors: Alan M Rathbun; Michelle D Shardell; Elizabeth A Stuart; Ann L Gruber-Baldini; Denise Orwig; Glenn V Ostir; Gregory E Hicks; Marc C Hochberg; Jay Magaziner Journal: Int J Geriatr Psychiatry Date: 2018-02-26 Impact factor: 3.485
Authors: I-Lin Hsu; Chia-Ming Chang; Deng-Chi Yang; Ya-Hui Chang; Chia-Chun Li; Susan C Hu; Chung-Yi Li Journal: Int J Environ Res Public Health Date: 2018-02-16 Impact factor: 3.390
Authors: Paula Kelly-Pettersson; Bodil Samuelsson; Maria Unbeck; Olav Muren; Martin Magnéli; Max Gordon; André Stark; Olof Sköldenberg Journal: Aging Clin Exp Res Date: 2019-04-26 Impact factor: 3.636